Increasing prevalence of atopic eczema driving growth of atopic dermatitis market

Date: 1 February 2020

According to a research report published by Azoth Analytics in October 2019, the Global Atopic Dermatitis Market was valued at USD 9005.16 million in the year 2018. Primarily, the growth in the market for Atopic Dermatitis will be chiefly supported by increasing prevalence of atopic eczema with treatment of this dermatologic condition depending upon the severity level of the disease. As high-income economies like United States have increasing size of population suffering from AD, and increment in number of allergens, Atopic Dermatitis market is expected to propel in the forecast period.

Global Atopic Dermatitis market will be majorly driven by growing number of allergens mainly food allergy. Demand for fast and accurate disease treatment is increasing with ever growing personal healthcare expenditure in various countries across the world. Also, government funding in hospitals in many countries continue to increase to provide consultation and treatment support to patients. With consumer awareness about good quality medical care and pharmaceutical companies’ engagement in development of newer and more efficient targeted therapies along with products in pipeline anticipated to spur market growth in the forecast period.

The Azoth Analytics research report titled Global AtopicDermatitis (AD) Market (2020 Edition) - Market Insight, Competition andForecast (2019-2024) has analysed and segmented the Atopic Dermatitis Market By Region (Americas, Europe, Asia Pacific, ROW) and By Country (US, Canada, Brazil, Mexico, Germany, UK, Japan, China, India, Australia) for the forecast period of 2019-2024. The report has analysed the Atopic Dermatitis Market By therapy Type (Biologic, Oral, Topical, Photo) and By End User (Hospital, Clinics, Research Labs).